- Scrip Originals
- Featured Topics
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Medix Inc.
The US obesity market is expected to double in size over the next decade with Novo Nordisk’s Saxenda driving the growth – but real progress for the pharmaceutical sector will only come when obesity drugs offer better outcomes than non-pharma methods.
- Medical Devices